Herbal medicine formula Huazhuo Tiaozhi granule ameliorates dyslipidaemia via regulating histone lactylation and miR-155-5p biogenesis
- PMID: 37919786
- PMCID: PMC10623728
- DOI: 10.1186/s13148-023-01573-y
Herbal medicine formula Huazhuo Tiaozhi granule ameliorates dyslipidaemia via regulating histone lactylation and miR-155-5p biogenesis
Abstract
Background: Huazhuo Tiaozhi granule (HTG) is a herbal medicine formula widely used in clinical practice for hypolipidaemic effects. However, the molecular mechanisms underlying dyslipidaemia treatment have not been well elucidated.
Results: A significant reduction in the levels of total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) was observed in the serum of patients with dyslipidaemia after HTG treatment, without disruption in the levels of aspartate transaminase (AST), alanine transaminase (ALT), urea nitrogen (BUN), and creatinine (Cr). The dyslipidaemia rat model was induced by a high-fat diet and treated with Xuezhikang (0.14 g/kg/d) or HTG (9.33 g crude herb/kg/day) by gavage for 8 weeks. Body weight and liver index were markedly decreased in dyslipidaemic rats after treatment with Xuezhikang or HTG. HTG administration markedly ameliorated hyperlipidaemia by decreasing the levels of TC and LDL-C in serum and hepatic lipid accumulation. In vitro, lipid accumulation in LO2 and HepG2 cells was alleviated by serum treatment with HTG. High lactylation was observed in 198 proteins, including lactylation of histone H2B (K6), H4 (K80). Deep sequencing of microRNAs showed that miR-155-5p was significantly downregulated.
Conclusions: This study demonstrates that HTG is an effective and safe formula for treating dyslipidaemia, which promotes lactylation in hepatocytes, and the retardation of miR-155-5p biogenesis.
Keywords: Dyslipidaemia; Herbal medicine formula; Histone; Huazhuo Tiaozhi granule; Lactylation; miR-155-5p.
© 2023. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures






Similar articles
-
Gan-Jiang-Ling-Zhu decoction alleviates hepatic steatosis in rats by the miR-138-5p/CPT1B axis.Biomed Pharmacother. 2020 Jul;127:110127. doi: 10.1016/j.biopha.2020.110127. Epub 2020 Apr 20. Biomed Pharmacother. 2020. PMID: 32325349
-
Artemisia capillaris formula inhibits hepatic steatosis via an miR‑122‑induced decrease in fatty acid synthase expression in vivo and in vitro.Mol Med Rep. 2016 Jun;13(6):4751-8. doi: 10.3892/mmr.2016.5131. Epub 2016 Apr 14. Mol Med Rep. 2016. PMID: 27081834
-
[Difference of lipid-lowering efficacy of "Xinjianqu" before and after fermentation and its mechanism based on LKB1-AMPK pathway and 16S rDNA sequencing technology].Zhongguo Zhong Yao Za Zhi. 2023 Apr;48(8):2146-2159. doi: 10.19540/j.cnki.cjcmm.20230112.301. Zhongguo Zhong Yao Za Zhi. 2023. PMID: 37282903 Chinese.
-
[Gynostemma pentaphyllum saponins alleviate non-alcoholic fatty liver disease in rats by regulating intestinal flora and short-chain fatty acid metabolism].Zhongguo Zhong Yao Za Zhi. 2022 May;47(9):2500-2508. doi: 10.19540/j.cnki.cjcmm.20211208.401. Zhongguo Zhong Yao Za Zhi. 2022. PMID: 35531697 Chinese.
-
An in vitro and in vivo study of a 4-herb formula on the management of diet-induced metabolic syndrome.Phytomedicine. 2018 Mar 15;42:112-125. doi: 10.1016/j.phymed.2018.03.028. Epub 2018 Mar 15. Phytomedicine. 2018. PMID: 29655677
Cited by
-
Histone Lactylation in Diseases: Regulation by Traditional Chinese Medicine and Therapeutic Implications.Drug Des Devel Ther. 2025 Jul 29;19:6435-6459. doi: 10.2147/DDDT.S524008. eCollection 2025. Drug Des Devel Ther. 2025. PMID: 40756263 Free PMC article. Review.
-
Comparative Proteome Profiling of Extracellular Vesicles from Three Growth Phases of Haematococcus pluvialis under High Light and Sodium Acetate Stresses.Int J Mol Sci. 2024 May 16;25(10):5421. doi: 10.3390/ijms25105421. Int J Mol Sci. 2024. PMID: 38791459 Free PMC article.
-
Lactylation Modification in Cardiometabolic Disorders: Function and Mechanism.Metabolites. 2024 Apr 12;14(4):217. doi: 10.3390/metabo14040217. Metabolites. 2024. PMID: 38668345 Free PMC article. Review.
-
Lactate transporter MCT4 regulates the hub genes for lipid metabolism and inflammation to attenuate intracellular lipid accumulation in non-alcoholic fatty liver disease.Genes Dis. 2025 Feb 15;12(4):101554. doi: 10.1016/j.gendis.2025.101554. eCollection 2025 Jul. Genes Dis. 2025. PMID: 40330148 Free PMC article.
-
Lactate Metabolism and Lactylation Modification: New Opportunities and Challenges in Cardiovascular Disease.MedComm (2020). 2025 Jul 1;6(7):e70269. doi: 10.1002/mco2.70269. eCollection 2025 Jul. MedComm (2020). 2025. PMID: 40599233 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases